The improved but unfinished business of stroke risk stratification in atrial fibrillation;Avances incompletos en la estratificación del riesgo de ictus en la fibrilación auricular

Revista Espanola de Cardiologia

Volumn 64, Issue 8, 2011, Pages 639-641

  Banerjee, Amitava ^a   Marín, Francisco ^a,b   Lip, Gregory Y H ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR RISK; HEART ATRIUM FIBRILLATION; REVIEW; RISK ASSESSMENT; STROKE;

EID: 80052966153     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1016/j.recesp.2011.04.005     Document Type: Article

References (15)

1. D.M. Lloyd-Jones, T.J. Wang, E.P. Leip, M.G. Larson, D. Levy, and R.S. Vasan Lifetime risk for development of atrial fibrillation: the Framingham Heart Study Circulation 110 2004 1042 1046 (Pubitemid 39319000)
2. T.A. Gaziano, C.R. Young, G. Fitzmaurice, S. Atwood, and J.M. Gaziano Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort Lancet 371 2008 923 931 (Pubitemid 351375276)
3. 2 score=1]: simplifying stroke risk assessment and thromboprophylaxis in real-life clinical practice Thromb Haemost 103 2010 683 685
4. G.Y. Lip, and J.L. Halperin Improving stroke risk stratification in atrial fibrillation Am J Med 123 2010 484 488
5. A.J. Camm, P. Kirchhof, G.Y. Lip, U. Schotten, I. Savelieva, and S. Ernst Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Eur Heart J 31 2010 2369 2429
6. B.F. Gage, A.D. Waterman, W. Shannon, M. Boechler, M.W. Rich, and M.J. Radford Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation JAMA 285 2001 2864 2870 (Pubitemid 32537350)
7. L. Gorin, L. Fauchier, E. Nonin, A. De Labriolle, K. Haguenoer, and P. Cosnay Antithrombotic treatment and the risk of death and stroke in patients with atrial fibrillation and a CHADS2 score=1 Thromb Haemost 103 2010 833 840
8. G. Karthikeyan, and J.W. Eikelboom The CHADS2 score for stroke risk stratification in atrial fibrillation - friend or foe? Thromb Haemost 104 2010 45 48
9. G.Y. Lip, R. Nieuwlaat, R. Pisters, D.A. Lane, and H.J. Crijns Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation Chest 137 2010 263 272
10. J.B. Olesen, G.Y. Lip, M.L. Hansen, P.R. Hansen, J.S. Tolstrup, and J. Lindhardsen Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study BMJ 342 2011 d124
11. M. Rodríguez-Mañero, A. Cordero, V. Bertomeu- González, J. Moreno-Arribas, V. Bertomeu-Martínez, and P. Mazón Impacto de los nuevos criterios para el tratamiento anticoagulante de la fibrilación auricular Rev Esp Cardiol 64 2011 649 653
12. T.P. Van Staa, E. Setakis, G.L. Di Tanna, D.A. Lane, and G.Y. Lip A comparison of risk stratification schemes for stroke in 79,884 atrial fibrillation patients in general practice J Thromb Haemost 9 2011 39 48
13. I.M. Ogilvie, N. Newton, S.A. Welner, W. Cowell, and G.Y. Lip Underuse of oral anticoagulants in atrial fibrillation: a systematic review Am J Med 123 2010 638 645
14. D.A. Garcia, R.D. Lopes, and E.M. Hylek New-onset atrial fibrillation and warfarin initiation: high risk periods and implications for new antithrombotic drugs Thromb Haemost 104 2010 1099 1105
15. I. Ahrens, G.Y. Lip, and K. Peter New oral anticoagulant drugs in cardiovascular disease Thromb Haemost 104 2010 49 60